Agilent Poroshell 120 HPLC columns
Watch the Video and Download the Notes! Ron Majors leads the way to getting more speed and resolution from any HPLC, using the power of Agilent Poroshell 120 columns to transfer your existing method.
Agilent Poroshell 120 HPLC columns give you speed and resolution like a sub-2 μm column with up to 50% less back pressure. They are made by Agilent using a proprietary single-step coacervation process, to improve reproducibility. And they have standard frits, so they are more forgiving for dirty samples.
In this video, Ron Majors and John Henderson demonstrate how to optimize your method using Agilent Poroshell 120.
Poroshell 120 will help you get more from your 400 bar HPLC, and, because Poroshell 120 can be used at pressures up to 600 bar, you can optimize your UHPLC results, too.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
